Table III.
Statistical power based on expected event rates in control patients and relative risk reductions from full drug coverage
Proportion of control patients experiencing primary outcome | Relative risk reduction from full drug coverage |
||||
---|---|---|---|---|---|
0.15 | 0.2 | 0.25 | 0.3 | 0.35 | |
0.2 | 0.70 | 0.92 | 0.99 | 1.0 | 1.0 |
0.25 | 0.79 | 0.96 | 1.0 | 1.0 | 1.0 |
0.3 | 0.85 | 0.98 | 1.0 | 1.0 | 1.0 |
0.35 | 0.89 | 0.99 | 1.0 | 1.0 | 1.0 |
0.4 | 0.92 | 1.0 | 1.0 | 1.0 | 1.0 |